Length of StayLEIANCT07769645
Length of Stay in Emergency Department: Impact of Anticipated Blood Sampling (LEIA)
An observational study of Length of Stay and Blood Sampling, run by Centre Hospitalier de Roubaix at 1 site in France.
Trial summary
The number of emergency department visits is constantly increasing France. Over the past three decades, the figure has risen from 10 million to more than 20 million visits per year. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Length of Stay, Blood Sampling, Crowding
- What is being tested?
- Anticipated blood sampling and No Anticipated Blood Sampling
- Type of treatment
- Surgery or procedure
- How many people
- 28,421 participants
- Where
- 1 siteFrance
- Study dates
- 1 Jan 2025to 4 Apr 2026
- How long will I take part?
- 12 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All patients admitted in ED between 01/01/2025and 12/31/2025 wha had blood sampling.
Who may be able to join
- 18 years and older
- Blood sampling realized in ED
Who cannot join
- Patients without triage
- Patients without complaint
- Patient's refusal
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Impact of Anticipated Blood Sampling on Length of Stay in Emergency Department: a Single-center Observational Retrospective Study With Propensity Score Matching.
The number of emergency department visits is constantly increasing France. Over the past three decades, the figure has risen from 10 million to more than 20 million visits per year. This is often attributed to a shortage of available primary care physicians and patients' inability to obtain timely appointments, whether for general practice or specialist consultations. It should also be noted that following the COVID-19 pandemic, the resurgence in emergency department attendance has further strained services. An aging population is associated with more advanced chronic conditions that are prone to decompensation, as well as more frequent acute illnesses resulting from increasing age-related frailty.
In France, the healthcare system encompasses 719 emergency departments, predominantly located in public healthcare institutions. Emergency departments manage medical, psychiatric, surgical, and traumatological emergencies in both children and adults. The current context is further characterized by a reduction in the number of available downstream inpatient beds nationwide, with an average decrease of approximately 1,390 beds per year between 2014 and 2023.
Read more
These various factors contribute to high emergency department utilization rates and occupancy levels. Emergency department length of stay has been shown to impact in-hospital mortality, particularly among patients aged 75 and over, and also negatively affects patient experience as well as the mental health of healthcare workers. One of the key challenges is to identify ways of reducing emergency department length of stay in order to improve patient flow and thereby decrease occupancy rates. Better control of these factors may also reduce morbidity and mortality associated with overcrowded emergency departments, as well as mean inpatient length of stay.
Emergency department length of stay depends on multiple factors, including waiting time before triage and placement, time to medical advice, time to blood sampling and imaging results when ordered, and time to specialist consultation when required. Additional delays may also arise from waiting for an inpatient bed to become available. All of these steps affect length of stay but are necessary to establish an accurate diagnosis and determine the appropriate disposition for each patient. Triage, using the FRENCH scale applied to patients in this study, may itself have an impact when performed rigorously, although blood tests have been shown to outperform algorithm-based triage in predicting short-term mortality. However, when unnecessary tests are performed through systematic blood sampling, emergency department length of stay is prolonged.
In the study by Strada, which evaluated anticipated blood sampling for abdominal pain, chest pain, and non-traumatic bleeding, a benefit was identified only for chest pain. Another study, conducted on a small sample, found no influence of blood testing on emergency department length of stay.
A further study evaluated point-of-care testing in the emergency department, which significantly reduced the time between test ordering and result availability, but demonstrated no impact on emergency department length of stay.
At the emergency department of the Centre Hospitalier de Roubaix, an increase in admissions and time to first medical contact has been observed, and several protocols have already been implemented to improve length of stay. Since November 2024, a high-flow procedure has been introduced enabling anticipated blood sampling prior to the first medical contact.
The primary objective of the study is to evaluate the impact of anticipated blood sampling on emergency department length of stay. Secondary objectives include the impact of anticipated blood sampling on length of stay according to patient disposition, and its impact on time to first medical contact.
- Conditions
- Length of Stay, Blood Sampling, Crowding
- Being tested
- Anticipated blood sampling, No Anticipated Blood Sampling
- Keywords
- Overcrowding, Emergency Department, Anticipated Blood Sampling, propensity score
- Medical subject headings
- Crowding, Emergencies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Anticipated blood samplingProcedure or surgery
Blood sampling was considered as anticipated if it has been realized a least 103 minutes before medical advice.
No Anticipated Blood SamplingProcedure or surgery
If blood sampling was realized between 103 minutes before medical advice a medical advice or after.
| Study group | Role | What they receive |
|---|---|---|
| No ABS | Patient who don't have anticipated blood sampling Receives: Procedure: No Anticipated Blood Sampling | |
| ABS | Patient who have anticipated blood sampling Receives: Procedure: Anticipated blood sampling |
What is being measured
The primary outcome is the main question the study is designed to answer.
lenght of stay
Delay between admission and discharge of emergency department
Measured: From ED admission to ED discharge, assessed over a 12-month period (January 1 to December 31, 2025)
Secondary outcomes (1)
Time to doctor
Delay between admissions and first medical advice in ED
Measured: From ED admission to ED discharge, assessed over a 12-month period (January 1 to December 31, 2025)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Aug 2026
- Study start1 Jan 2025
- Primary completion31 Dec 2025
- Study completion4 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Length of StayStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 28,421 participants (actual)
- Target duration
- 12 Months
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Roubaix
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rémy DIESNIS, Centre Hospitalier de Roubaix
- Investigators
- Rémy Diesnis, MD, Principal investigator, Centre Hospirtalier de Roubaix
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07769645
- Sponsor's protocol ID
- 2026-005
- Acronym
- LEIA
- Status last verified
- Apr 2026
- First submitted
- 9 Aug 2026
- Last updated
- 18 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Anticipated Blood Sampling on Length of Stay in Emergency Department: a Single-center Observational Retrospective Study With Propensity Score Matching.
- ClinicalTrials.gov ID
- NCT07769645
- Acronym / sponsor ID
- LEIA / 2026-005
- Conditions
- Length of Stay, Blood Sampling, Crowding
- Keywords
- Overcrowding, Emergency Department, Anticipated Blood Sampling, propensity score
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 28,421 participants (actual)
- Lead sponsor
- Centre Hospitalier de RoubaixUniversity, hospital or other
- Study start
- 1 Jan 2025 (actual)
- Primary completion
- 31 Dec 2025 (actual)
- Study completion
- 4 Apr 2026 (actual)
- First posted
- 18 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The number of emergency department visits is constantly increasing France. Over the past three decades, the figure has risen from 10 million to more than 20 million visits per year. This is often attributed to a shortage of available primary care physicians and patients' inability to obtain timely appointments, whether for general practice or specialist consultations. It should also be noted that following the COVID-19 pandemic, the resurgence in emergency department attendance has further strained services. An aging population is associated with more advanced chronic conditions that are prone to decompensation, as well as more frequent acute illnesses resulting from increasing age-related frailty.
In France, the healthcare system encompasses 719 emergency departments, predominantly located in public healthcare institutions. Emergency departments manage medical, psychiatric, surgical, and traumatological emergencies in both children and adults. The current context is further characterized by a reduction in the number of available downstream inpatient beds nationwide, with an average decrease of approximately 1,390 beds per year between 2014 and 2023.
These various factors contribute to high emergency department utilization rates and occupancy levels. Emergency department length of stay has been shown to impact in-hospital mortality, particularly among patients aged 75 and over, and also negatively affects patient experience as well as the mental health of healthcare workers. One of the key challenges is to identify ways of reducing emergency department length of stay in order to improve patient flow and thereby decrease occupancy rates. Better control of these factors may also reduce morbidity and mortality associated with overcrowded emergency departments, as well as mean inpatient length of stay.
Emergency department length of stay depends on multiple factors, including waiting time before triage and placement, time to medical advice, time to blood sampling and imaging results when ordered, and time to specialist consultation when required. Additional delays may also arise from waiting for an inpatient bed to become available. All of these steps affect length of stay but are necessary to establish an accurate diagnosis and determine the appropriate disposition for each patient. Triage, using the FRENCH scale applied to patients in this study, may itself have an impact when performed rigorously, although blood tests have been shown to outperform algorithm-based triage in predicting short-term mortality. However, when unnecessary tests are performed through systematic blood sampling, emergency department length of stay is prolonged.
In the study by Strada, which evaluated anticipated blood sampling for abdominal pain, chest pain, and non-traumatic bleeding, a benefit was identified only for chest pain. Another study, conducted on a small sample, found no influence of blood testing on emergency department length of stay.
A further study evaluated point-of-care testing in the emergency department, which significantly reduced the time between test ordering and result availability, but demonstrated no impact on emergency department length of stay.
At the emergency department of the Centre Hospitalier de Roubaix, an increase in admissions and time to first medical contact has been observed, and several protocols have already been implemented to improve length of stay. Since November 2024, a high-flow procedure has been introduced enabling anticipated blood sampling prior to the first medical contact.
The primary objective of the study is to evaluate the impact of anticipated blood sampling on emergency department length of stay. Secondary objectives include the impact of anticipated blood sampling on length of stay according to patient disposition, and its impact on time to first medical contact.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Target follow-up
- 12 Months
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| No ABS | – | Procedure: No Anticipated Blood SamplingPatient who don't have anticipated blood sampling |
| ABS | – | Procedure: Anticipated blood samplingPatient who have anticipated blood sampling |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All patients admitted in ED between 01/01/2025and 12/31/2025 wha had blood sampling.
Key inclusion criteria (2 listed)
- 18 years and older
- Blood sampling realized in ED
Key exclusion criteria (3 listed)
- Patients without triage
- Patients without complaint
- Patient's refusal
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Anticipated blood samplingBlood sampling was considered as anticipated if it has been realized a least 103 minutes before medical advice. | Procedure or surgery | ABS |
| No Anticipated Blood SamplingIf blood sampling was realized between 103 minutes before medical advice a medical advice or after. | Procedure or surgery | No ABS |
Primary outcome
lenght of stay
Time frame: From ED admission to ED discharge, assessed over a 12-month period (January 1 to December 31, 2025)
Delay between admission and discharge of emergency department
1 secondary outcome
Time to doctor
Time frame: From ED admission to ED discharge, assessed over a 12-month period (January 1 to December 31, 2025)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Length of Stay
Not yet recruitingPhase 3
Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure
Heart Failure, Acute Decompensated Heart Failure
Not yet recruitingPhase 2
Furosemide vs Placebo in Severe Preeclampsia Postpartum
Severe Preeclampsia
Not yet recruitingObservational study
Comparison of IV Dexmedetomidine Versus Clonidine Versus no Alpha 2 Agonist on Emergency Delirium, PACU Length of Stay and Time to Hospital Discharge in Children Undergoing (Adeno)Tonsillectomy: a Prospective Observational Study
Emergency Delirium, Postoperative Delirium (POD)
RecruitingPhase 3
A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
Coronary Artery Disease (CAD), Coronary Artery Bypass Graft Surgery(CABG)
Not yet recruitingPhase 2
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Suicidal Ideation, Suicidal Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rémy Diesnis, MD principal investigator
Centre Hospirtalier de Roubaix
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Length of Stay and Blood Sampling, run by Centre Hospitalier de Roubaix at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
lenght of stay (time frame: From ED admission to ED discharge, assessed over a 12-month period (January 1 to December 31, 2025)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2026.